Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)
CompletedOBSERVATIONAL
Enrollment
151
Participants
Timeline
Start Date
July 30, 2023
Primary Completion Date
February 28, 2024
Study Completion Date
February 28, 2024
Conditions
Colorectal CancerGastric Cancer (GC)CapecitabineHand Foot Syndrome
Trial Locations (2)
Unknown
Ankara Etlik City Hospital, Ankara
Gazi University, Ankara
All Listed Sponsors
lead
Gazi University
OTHER
NCT07177560 - Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS) | Biotech Hunter | Biotech Hunter